ABBV
AbbVie Inc.·Healthcare
215.70
0.559%(+1.20)
Market ClosedLast Updated: — ET
52W L: $181.7352W H: $244.81
ABBV NEWS
247wallst.com
4h ago
The Dividend Stocks That Generate $60,000 Tax-Free Inside a Roth (And What They Cost You in a Taxable Account)
Holding a high-yield dividend portfolio in a taxable account at the 24% federal bracket means writing the IRS a $14,400 check every year on $60,000 of income that should have been yours.
fool.com
15h ago
The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech
When investors take a risk-off attitude, stocks with attractive, growing dividends are often their safe-haven option.
fool.com
20h ago
Healthcare Stocks Are on Fire -- Don't Miss These Opportunities
Innovation, regulatory policy, and demographics are driving healthcare stocks higher. Healthcare companies have also posted strong first-quarter results.
prnewswire.com
1d ago
AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
The positive opinion is supported by data from the Phase 3 M20-350 study evaluating the safety and efficacy of MAVIRET ® in adults with acute hepatitis C virus (HCV) infection. MAVIRET is a direct-acting antiviral (DAA) treatment currently approved in the European Union for chronic HCV infection in adults and children aged 3 years and older.
247wallst.com
1d ago
The Dividend Stocks That Can Replace a $65,000 Income and What They'll Cost You
Dividend-growth blue chips like Coca-Cola double income in nine years despite lower starting yields, while high-yield BDCs and REITs with frozen payouts risk delivering less income over a decade than lower-yield growers.
prnewswire.com
1d ago
AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
- Data from novel Top1i ADC and T-cell engager platforms highlight potential within solid tumors and blood cancers, including oral presentations in prostate cancer, small cell lung cancer, platinum-resistant ovarian cancer and multiple myeloma - NORTH CHICAGO, Ill., May 21, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it will present new data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago demonstrating the depth and breadth of its oncology pipeline.
